Click Here for 5% Off Your First Aladdin Purchase!

Depemokimab (anti-IL-5) - Primary antibody, specific to IL5, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Interleukin-5 inhibitor

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab182926
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab182926-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab182926-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$519.90
Ab182926-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,399.90
Ab182926-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,239.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

View related series
Accession#:P05113 Gene ID:3567 IL5

Basic Description

Product NameDepemokimab (anti-IL-5) - Primary antibody, specific to IL5, >95% (SDS-PAGE&SEC), high purity, Human IgG1
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Biochemical and Physiological MechanismsFactor that induces terminal differentiation of late-developing B-cells to immunoglobulin secreting cells.
SpecificityIL5
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionINHIBITOR of Interleukin-5 inhibitor
Product Description

Depemokimab (anti-IL-5) is a humanized monoclonal antibody (IgG1, kappa) directed against IL-5. Depemokimab (anti-IL-5) can be used for research of asthma.

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE145.8 kDa
Purification MethodProtein A purified
Purity>95% (SDS-PAGE&SEC)
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS2243274-14-6

Images

Depemokimab (anti-IL-5) (Ab182926) - ELISA
Immobilized Human IL-5-His Tag Protein at 2.0 μg/mL can bind Depemokimab (anti-IL-5) (Ab182926) with the EC ₅₀ of 96.02 ng/mL.

Depemokimab (anti-IL-5) (Ab182926) - SEC
The purity of Depemokimab (anti-IL-5) (Ab182926) is more than 95% verified by HPLC.

Associated Targets

IL5 Tclin Interleukin-5 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

Solution Calculators